Related Experiment Video
Updated: Jan 18, 2026
07:49
Isolation and Analysis of Aortic Arch and Root Lesions in an Atherosclerotic Mouse Model
Published on: February 14, 2025
2.1K
Lipoprotein(a) and aortic stenosis: Practical insights
Kyriakos Dimitriadis1, Konstantinos G Kyriakoulis1, Nikolaos Pyrpyris1
1First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.
Summary
High levels of Lipoprotein(a) (Lp(a)) are linked to aortic stenosis (AS) development and progression. Lp(a)-lowering therapies may offer new treatment strategies for AS patients.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
Background:
- Lipoprotein(a) (Lp(a)) is increasingly recognized for its role in cardiovascular diseases.
- Elevated Lp(a) levels are associated with adverse cardiovascular outcomes.
Purpose of the Study:
- To review current literature and research on the relationship between aortic stenosis (AS) and Lp(a).
- To provide updated data for basic and clinical scientists.
Main Methods:
- Comprehensive literature review of observational and genetic studies.
- Analysis of the interplay between AS pathogenesis and Lp(a).
Main Results:
- Lp(a) significantly contributes to the pathogenesis of AS.
- Patients with AS exhibit higher Lp(a) levels.
- Increased Lp(a) is linked to a higher risk of AS development.
Conclusions:
- Elevated Lp(a) predicts AS presence, development, and progression.
- Lp(a) may offer insights into bioprosthetic valve function.
- Further research on Lp(a)-lowering agents is crucial for AS treatment.
Related Concept Videos
01:26Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
01:30Atherosclerosis I: Introduction
933
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
933
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
475
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
475
01:25Aortic Regurgitation III: Medical Management
401
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
401
01:30Peripheral Artery Disease I: Introduction
320
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
320
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
308
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
308